Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Avant Immunotherapeutics (MM) (AVAND)
Avant Immunotherapeutics (MM) (AVAND) Actualités

Avant Immunotherapeutics (MM) (AVAND)

10,58

0,00

(0,00%)

Fermé 12 Juin 10:00PM

0,00

0,00

(0,00%)

Après les heures de négociation: -

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Avant Immunotherapeutics Inc - Amended Statement of Ownership (SC 13G/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No...

Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Avant Immunotherapeutics Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Avant Immunotherapeutics Inc - Statement of Beneficial Ownership (SC 13D)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934...

Avant Immunotherapeutics Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Avant Immunotherapeutics Inc - Annual Report (10-K)

QuickLinks -- Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE...

Avant Immunotherapeutics Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Avant Immunotherapeutics Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Avant Immunotherapeutics Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Avant Immunotherapeutics Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Avant Immunotherapeutics Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Avant Immunotherapeutics Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Avant Immunotherapeutics Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Avant Immunotherapeutics Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Avant Immunotherapeutics Inc - Statement of Beneficial Ownership (SC 13D)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

COMMERZBANK Aktiengesell...

Bmo Conservative Etf Por...

Sagaliam Acquisition

ASR Nederland NV (PK)

iShares MSCI Philippines

Pacer Trendpilot Fund of...

Danske Bank AVS (ID)

SPDR S&P Internet ETF

RHB Bank Berhad (PK)

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.